库珀视觉在亚太四个国家推出了MiSight 1 天近视控制镜头, 临床证据显示近视的进展在儿童中减缓了50%. CooperVision launches MiSight 1-day myopia control lenses in four Asia Pacific countries, backed by clinical evidence showing 50% slower myopia progression in children.

Cooper Vision在澳大利亚、新西兰、南非和以色列推出了MyDay MiSight 1天短视控制隐形眼镜, CooperVision has launched its MyDay MiSight 1-day myopia control contact lenses in Australia, New Zealand, South Africa, and Israel, marking the product’s entry into the Asia Pacific region. 水凝制成的每日一次性透镜在临床试验中显示近视的进展减少了约50%,是儿童软隐形眼镜最长期运行的研究的一部分. The daily disposable lenses, made with silicone hydrogel, have shown about a 50% reduction in myopia progression in clinical trials and are part of the longest-running soft contact lens study for children. 这一扩张支持了该公司的全球推动,使循证近视管理更易于利用,预计不久还会有更多的亚太市场。 The expansion supports the company’s global push to make evidence-based myopia management more accessible, with additional Asia Pacific markets expected soon.